Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
2024-12-24 08:421992 view
2024-12-24 08:322478 view
2024-12-24 07:511625 view
2024-12-24 07:452145 view
2024-12-24 07:092285 view
2024-12-24 06:201706 view
More than 80 years after it was sunk by Japanese forces during World War II, the U.S. Navy said Mond
PHOENIX (AP) — Musicians in a cramped space under a Phoenix stage send up the familiar tones of “The
Monsanto on Monday was ordered to pay $857 million to a group of seven former students and parent vo
